Ionis Pharmaceuticals Stock Target Price
| IONS Stock | USD 33.94 1.46 4.12% |
Ionis Pharmaceuticals fundamentals help investors to digest information that contributes to Ionis Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Ionis Stock. The fundamental analysis module provides a way to measure Ionis Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ionis Pharmaceuticals stock.
Ionis | Target Price |
Ionis Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ionis Pharmaceuticals' direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ionis Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Ionis Pharmaceuticals by comparing valuation metrics of similar companies.Ionis Pharmaceuticals is currently under evaluation in target price category among its peers.
Ionis Pharmaceuticals ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Ionis Pharmaceuticals' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Ionis Pharmaceuticals' managers, analysts, and investors.Environmental | Governance | Social |
Ionis Fundamentals
| Return On Equity | -0.73 | ||||
| Return On Asset | -0.0725 | ||||
| Profit Margin | (0.45) % | ||||
| Operating Margin | (1.11) % | ||||
| Current Valuation | 4.32 B | ||||
| Shares Outstanding | 157.9 M | ||||
| Shares Owned By Insiders | 0.76 % | ||||
| Shares Owned By Institutions | 99.24 % | ||||
| Number Of Shares Shorted | 10.74 M | ||||
| Price To Earning | 101.16 X | ||||
| Price To Book | 8.09 X | ||||
| Price To Sales | 6.67 X | ||||
| Revenue | 787.65 M | ||||
| Gross Profit | (257.87 M) | ||||
| EBITDA | (230.01 M) | ||||
| Net Income | (366.29 M) | ||||
| Cash And Equivalents | 2.04 B | ||||
| Cash Per Share | 14.36 X | ||||
| Total Debt | 1.45 B | ||||
| Debt To Equity | 2.00 % | ||||
| Current Ratio | 8.18 X | ||||
| Book Value Per Share | 4.20 X | ||||
| Cash Flow From Operations | (307.51 M) | ||||
| Short Ratio | 7.97 X | ||||
| Earnings Per Share | (2.44) X | ||||
| Price To Earnings To Growth | 25.70 X | ||||
| Target Price | 61.36 | ||||
| Number Of Employees | 927 | ||||
| Beta | 0.39 | ||||
| Market Capitalization | 5.36 B | ||||
| Total Asset | 2.99 B | ||||
| Retained Earnings | (1.8 B) | ||||
| Working Capital | 2.19 B | ||||
| Current Asset | 837 M | ||||
| Current Liabilities | 148.88 M | ||||
| Net Asset | 2.99 B |
About Ionis Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ionis Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ionis Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ionis Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Ionis Stock Analysis
When running Ionis Pharmaceuticals' price analysis, check to measure Ionis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ionis Pharmaceuticals is operating at the current time. Most of Ionis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ionis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ionis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ionis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.